The American right's embrace of psychedelics represents a shift from counterculture to corporate capitalism
Source: https://www.theguardian.com/profile/kojo-koram. "Turn on, tune in, cash out … The US right used to fear psychedelics. Now it wants to sell them | Kojo Koram | The Guardian." April 28, 2026. www.theguardian.com
The Gist
The author argues that psychedelics went from being hated by conservatives in the 1960s to being loved by Trump and Republicans today, but this isn't because of science or helping people - it's because rich tech guys realized they can make billions of dollars selling psychedelic treatments. What used to be anti-establishment hippie drugs are now just another way for Silicon Valley to get richer.
Conclusion
The transformation of psychedelics from feared countercultural symbols to Republican-backed medical treatments reflects a fundamental shift driven by profit potential and Silicon Valley influence, not genuine policy reform
Premises
- Psychedelics have undergone a complete political reversal - from being feared by conservatives in the 1960s to being championed by Trump and the Republican right today
- Scientific research demonstrating therapeutic benefits has provided legitimacy, particularly among traditionally conservative groups like military veterans
- The primary driver of change is economic opportunity, with the psychedelic market predicted to exceed $3.3 billion by 2031
- Silicon Valley tech oligarchs like Peter Thiel and Sergey Brin are heavily investing in psychedelic companies, seeing massive profit potential in treating mental health disorders
- The alliance between Trump's administration and Silicon Valley capital is accelerating psychedelic policy reform for commercial rather than humanitarian reasons
- This shift represents a co-optation of what was once anti-establishment counterculture into mainstream finance capital and corporate interests
Assumptions
- Economic motives are more influential in policy change than scientific evidence or humanitarian concerns
- The involvement of wealthy tech investors fundamentally changes the nature and purpose of psychedelic reform
- Republican support for psychedelics is primarily opportunistic rather than based on genuine policy conviction
- Corporate control of psychedelic medicine will limit access and prioritize profit over patient welfare
- The original countercultural values associated with psychedelics are incompatible with their commercialization